ResearchMazindol Immediate-Release/Sustained-Release (IR/SR): A 50-Year Legacy of Multifaceted Mechanisms and Emerging Therapeutic Potential
ResearchOnce-Nightly Oxybate Dosing Preference and Nocturnal Experience with Twice-Nightly Oxybates: A Plain Language Summary of Publication
ResearchCardiovascular and Cardiometabolic Comorbidities in Central Disorders of Hypersomnolence: A Narrative Review
Sep 9, 2026Original ArticleOveporexton for Narcolepsy Type 1 — Results from Two Phase 3 TrialsWritten by 1 Roon author & 37 others Via The New England Journal of Medicine
ResearchCataplexy Response with Extended-Release Once-Nightly Sodium Oxybate: Post Hoc Responder Analyses from the Phase 3 REST-ON Clinical Trial
ResearchAtomoxetine and Spironolactone Combine to Reduce Obstructive Sleep Apnea Severity and Blood Pressure in Hypertensive Patients
ResearchRESTORE: Once-Nightly Oxybate Dosing Preference and Nocturnal Experience with Twice-Nightly Oxybates
ResearchEffects of Atomoxetine Plus a Hypnotic on Obstructive Sleep Apnea Severity in Patients with a Moderately Collapsible Pharyngeal Airway
ResearchThe Combination of Aroxybutynin and Atomoxetine in the Treatment of Obstructive Sleep Apnea (MARIPOSA): A Randomized Controlled Trial
ResearchEffect of FT218, a Once-Nightly Sodium Oxybate Formulation, on Disrupted Nighttime Sleep in Patients with Narcolepsy: Results from the Randomized Phase III REST-ON Trial
ResearchPreferences for Attributes of Sodium Oxybate Treatment: A Discrete Choice Experiment in Patients with Narcolepsy
ResearchOnce-Nightly Sodium Oxybate (FT218) Demonstrated Improvement of Symptoms in a Phase 3 Randomized Clinical Trial in Patients with Narcolepsy
ResearchDaytime Pharmacodynamic and Pharmacokinetic Evaluation of Low-Dose Sublingual Transmucosal Zolpidem Hemitartrate
ResearchEffect of Gaboxadol on Sleep in Adult and Elderly Patients with Primary Insomnia: Results from Two Randomized, Placebo-Controlled, 30-Night Polysomnography Studies